Vermillion

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Vermillion ( VRML) is engaged in the discovery, development and commercialization of diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. This stock is trading up 6% at $1.69 in recent trading.

Today's Range: $1.55-$1.85

52-week Range: $1.17-$9.49

Volume: 254,605

Three-Month Average Volume: 148,789

This stock is trending higher today after the company reported a $4.7 million net loss on $320,000 in revenue in the third quarter, vs. a $2.7 million loss on $413,000 in revenue during the same period last year.

>>20 Highest-Yielding Drug Stocks

From a technical standpoint, this stock has been stuck in a nasty downtrend for the past six months, with shares making mostly lower highs and lower lows. The stock is also currently trading well below both its 50-day and 200-day moving averages, which is bearish.

That said, traders can look to play the next major breakout that will trigger on a high-volume move above $2 and then $2.25. If we see that action soon, look for a run back towards $3.

If you liked this article you might like

Growth Seeker Portfolio: Market Disconnects the Dots

Growth Seeker Portfolio: Earnings Start to Give Clearer Picture

Growth Seeker Portfolio: Living Up to Our Name

5 Stocks That Could Be Squeezed Much Higher

Connected Cars Have Potential Not Just for Chipmakers, but Won't Always Move the Needle